Infertility, Female Clinical Trial
Official title:
Ovarian Rejuvenation Through Intra-ovarian Injection of Platelet Rich Plasma for Women With Premature Ovarian Insufficiency (POI) and Poor Ovarian Response (POR)
Verified date | September 2023 |
Source | Reproductive Medicine Associates of New Jersey |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The objective of this study is to perform a prospective randomized controlled trial seeking to characterize the effects of intra-ovarian injection of platelet rich plasma (PRP) on biomarkers of ovarian reserve as well as IVF outcomes in women with primary ovarian insufficiency (POI) and poor ovarian response (POR) who decline the use of an egg donor to establish a pregnancy.
Status | Completed |
Enrollment | 90 |
Est. completion date | July 21, 2023 |
Est. primary completion date | August 5, 2022 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 38 Years |
Eligibility | Inclusion criteria 1. POI according to ESHRE criteria (patient must fit both criteria): 1. presence of menstrual disturbance defined as oligo/amenorrhea for at least 4 months 2. biochemical confirmation as evidenced by an elevated FSH level >25 IU/L on two occasions > 4 weeks apart 2. POR defined by at least two prior cycles with POR (=3 oocytes retrieved with a conventional stimulation protocol, or a cancelled cycle due to poor response) 3. Patients declining ovum donation treatment Exclusion criteria 1. Age <18yo or >38yrs 2. Autoimmune or sex chromosome etiology of POI 3. Ongoing malignancy 4. Previous ovarian surgery 5. Previous gonadotoxic treatment 6. Anticoagulant use for which plasma infusion is contraindicated 7. FMR1 mutations 8. If the duration of the amenorrhea is more than 2 years, patients are discouraged to participate, although it is not an exclusion criterion. 9. Patients with only 1 ovary 10. BMI > 35 11. Male partner with <100,000 total motile spermatozoa per ejaculate (donor sperm is acceptable) 12. Surgically obtained sperm 13. Presence of hydrosalpinges that communicate with endometrial cavity 14. Single gene disorder or chromosomal rearrangement requiring a more detailed embryonic genetic analysis 15. Diagnosis of endometrial insufficiency: prior cycle with maximal endometrial thickness = 6mm, abnormal endometrial pattern (failure to attain a trilaminar appearance), persistent endometrial fluid 16. Use of a gestational carrier 17. Any contraindications to undergoing in vitro fertilization or gonadotropin stimulation 18. Known ovaries that are not accessible transvaginally. 19. Ovarian endometrioma(s) or dermoid cyst(s) identified via transvaginal ultrasound 20. FSH > 40iu/l |
Country | Name | City | State |
---|---|---|---|
Turkey | Acibadem University | Istanbul | |
United States | Reproductive Medicine Associates of New Jersey | Basking Ridge | New Jersey |
Lead Sponsor | Collaborator |
---|---|
Reproductive Medicine Associates of New Jersey |
United States, Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | number of participants with a mature oocyte retrieved- POI group | success or failure is determined by the retrieval of at least one mature oocyte | 24 hours post egg retrieval procedure | |
Primary | number of mature oocytes retrieved- POR group | the total number of mature oocytes retrieved | 24 hours post egg retrieval procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05969574 -
Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
|
||
Recruiting |
NCT05358483 -
PROspective Study of Mothers' and Infants' Social and Epidemiologic Determinants of Health
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Completed |
NCT03177538 -
Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders
|
Phase 4 | |
Completed |
NCT03638856 -
Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy
|
N/A | |
Completed |
NCT04052464 -
The Study of the Implantation Window From Endometrial Biopsy With Gene Expression Methods
|
||
Withdrawn |
NCT04753736 -
Immunophenotypage of RIF and RM Patients and Intrauterine Administration of PBMC
|
N/A | |
Completed |
NCT03349905 -
Deferred Versus Fresh Embryo Transfers
|
N/A | |
Completed |
NCT05076981 -
Progesterone Levels During Ovulation and Luteal Phase
|
||
Completed |
NCT04096027 -
Cabergoline Before or After Oocyte Collection for Follicular Resolution
|
Phase 4 | |
Recruiting |
NCT05980091 -
Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration.
|
Phase 1 | |
Terminated |
NCT01933633 -
Improved Fertility After Exercise in Overweight/Obese Women
|
N/A | |
Completed |
NCT01202656 -
Effect of Colony Stimulating Factor on Implantation and Pregnancy Rates Following IVF (in Vitro Fertilization)
|
Phase 1/Phase 2 | |
Terminated |
NCT01202643 -
Effect of Colony Stimulating Factor on Poor Endometrial Development During IVF
|
Phase 1/Phase 2 | |
Completed |
NCT01408615 -
A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)
|
||
Enrolling by invitation |
NCT05698550 -
The Role of Erzhi Tiangui Formula in Expected POR Women Undergoing IVF-ET
|
Phase 3 | |
Not yet recruiting |
NCT03910582 -
Personalized FET in RIF Patients With Displaced Dating
|
N/A | |
Completed |
NCT05440019 -
Evaluation of the Safety and Usability of the M3T Fertigo System and Its Calibration
|
||
Completed |
NCT05130125 -
Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer
|